The Valley Desk

NCT02710734 · Interventional trial

Risk Enabled Therapy After Initiating Neoadjuvant Chemotherapy for Bladder Cancer (RETAIN)

Overall registry status Completed

Phase 2

Conditions Urothelial Carcinoma of the Bladder

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov